Skip to main content

Table 1 Baseline characteristic of the study population (n = 114)

From: Survival of HIV infected patients on maintenance hemodialysis in Cameroon: a comparative study

Variables

HIV-

N = 57

HIV +

N = 57

p

Gender n (%)

 Female

30 (52.6)

30 (52.6)

 

 Male

27 (47.4)

27 (47.4)

1

Age (years)

Mean ± SDa

46.25 ± 11.41

46.00 ± 11.40

0.909

Matrimonial status n (%)

 Married

42 (73.7)

27 (47.4)

 

 Non married

15 (26.3)

30 (52.6)

0.004

Co morbidity n (%)

 History of hypertension

51 (89.5)

35 (61.4)

< 0.001

 History of diabetes

15 (26.3)

9 (15.8)

0.168

 Hepatitis B infection

3 (5.3)

4 (7.0)

1

 Hepatitis C infection

8 (14.0)

8 (14.0)

1

Baseline nephropathy

 HIVb

0 (0.0)

29 (50.9)

 

 CGNc

19 (33.3)

8 (14.0)

 

 Unknown

11 (19.3)

11 (19.3)

 

 Hypertension

15 (26.3)

7 (12.3)

 

 Diabetes

12 (21.1)

2 (3.5)

< 0.001

Vascular access at initiation n (%)

 Temporary CVCd

45 (78.9)

52 (91.2)

 

 AVFe

12 (21.1)

5 (8.8)

0.066

Biologic Data   

Mean ± SDa

 Haemoglobin

7.86 ± 1.98

7.12 ± 1.70

0.045

 Calcemia

76.59 ± 14.78

73.64 ± 16.78

0.370

 Phosphoremia

71.13 ± 28.84

67.88 ± 35.47

0.639

CD4 count n = 49

 Median (IQRf)

212 (138–455)

–

–

 CD4 count<200cells/mm3 n (%)

23 (46.9)

–

–

Use of c-ARTg n (%)

44 (77.2)

–

–

Drug regimen n (%)(n = 44)

 

–

–

 1st line

37 (84.1)

–

–

 2nd line

6 (13.6)

–

–

Hospitalisation rate n (%)

10 (17.5)

12 (21.1)

0.635

  1. aSD Standard deviation, bHIV Human immune deficiency virus, cCGN Chronic glomerulonephritis, dCVC Central venous catheter, eAVF Arterio- venous fistula, fIQR Interquartile range, gc-ART Combined antiretroviral treatment
  2. Values in bold are significant (p < 0.05)